Total Payments
$4,070
2024 Payments
$385.70
Companies
21
Transactions
63
Medicare Patients
262
Medicare Billing
$16,590
Payment Breakdown by Category
Food & Beverage$2,797 (68.7%)
Consulting$675.00 (16.6%)
Education$597.80 (14.7%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,797 | 56 | 68.7% |
| Consulting Fee | $675.00 | 1 | 16.6% |
| Education | $597.80 | 6 | 14.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Fresenius Kabi USA, LLC | $899.83 | 2 | $0 (2023) |
| Myriad Genetic Laboratories, Inc. | $696.82 | 11 | $0 (2024) |
| Lilly USA, LLC | $523.41 | 9 | $0 (2024) |
| Merck Sharp & Dohme LLC | $272.57 | 12 | $0 (2023) |
| Gilead Sciences, Inc. | $228.33 | 4 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $207.81 | 5 | $0 (2024) |
| Tactile Systems Technology Inc | $179.66 | 2 | $0 (2024) |
| Daiichi Sankyo Inc. | $145.36 | 2 | $0 (2023) |
| Regeneron Healthcare Solutions, Inc. | $132.96 | 1 | $0 (2021) |
| PUMA BIOTECHNOLOGY, INC. | $129.00 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $385.70 | 7 | Tactile Systems Technology Inc ($179.66) |
| 2023 | $1,705 | 20 | Fresenius Kabi USA, LLC ($899.83) |
| 2022 | $984.50 | 18 | Lilly USA, LLC ($250.05) |
| 2021 | $995.24 | 18 | Myriad Genetic Laboratories, Inc. ($274.36) |
All Payment Transactions
63 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/09/2024 | Lilly USA, LLC | VERZENIO (Drug) | Food and Beverage | In-kind items and services | $22.02 | General |
| Category: Oncology | ||||||
| 06/26/2024 | Myriad Genetic Laboratories, Inc. | MYRISK (Device) | Food and Beverage | In-kind items and services | $67.49 | General |
| Category: ONCOLOGY | ||||||
| 05/20/2024 | Myriad Genetic Laboratories, Inc. | MYRISK (Device) | Food and Beverage | In-kind items and services | $80.13 | General |
| Category: ONCOLOGY | ||||||
| 05/07/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $16.91 | General |
| 04/16/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $19.49 | General |
| Category: Oncology | ||||||
| 03/17/2024 | Tactile Systems Technology Inc | Flexitouch Plus (Device), Entre Plus | Food and Beverage | In-kind items and services | $88.41 | General |
| Category: PNEUMATIC COMPRESSOR | ||||||
| 03/05/2024 | Tactile Systems Technology Inc | Flexitouch Plus (Device), Entre Plus | Food and Beverage | In-kind items and services | $91.25 | General |
| Category: PNEUMATIC COMPRESSOR | ||||||
| 11/30/2023 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $29.57 | General |
| Category: ONCOLOGY | ||||||
| 10/25/2023 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $20.77 | General |
| Category: Oncology | ||||||
| 10/18/2023 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | Cash or cash equivalent | $21.66 | General |
| Category: Oncology | ||||||
| 09/25/2023 | Genmab U.S., Inc. | Tivdak (Drug) | Food and Beverage | In-kind items and services | $17.23 | General |
| Category: Oncology | ||||||
| 09/13/2023 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Oncology | ||||||
| 08/22/2023 | PFIZER INC. | PREMARIN (Drug), ESTRING | Food and Beverage | In-kind items and services | $18.86 | General |
| Category: WOMENS HEALTH | ||||||
| 08/15/2023 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $20.87 | General |
| Category: ONCOLOGY | ||||||
| 08/14/2023 | Seagen Inc. | — | Education | In-kind items and services | $99.99 | General |
| 07/12/2023 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | Cash or cash equivalent | $21.66 | General |
| Category: Oncology | ||||||
| 07/11/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $18.14 | General |
| Category: Biological | ||||||
| 06/22/2023 | Myriad Genetic Laboratories, Inc. | MYRISK (Device) | Food and Beverage | In-kind items and services | $119.54 | General |
| Category: ONCOLOGY | ||||||
| 06/19/2023 | Seagen Inc. | TUKYSA (Drug) | Food and Beverage | In-kind items and services | $19.38 | General |
| Category: Oncology | ||||||
| 06/02/2023 | Fresenius Kabi USA, LLC | Stimufend (Biological) | Consulting Fee | Cash or cash equivalent | $675.00 | General |
| Category: Biosimilars | ||||||
| 05/22/2023 | Myriad Genetic Laboratories, Inc. | MYRISK (Device) | Food and Beverage | In-kind items and services | $19.33 | General |
| Category: ONCOLOGY | ||||||
| 05/17/2023 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $23.15 | General |
| Category: ONCOLOGY | ||||||
| 04/27/2023 | Fresenius Kabi USA, LLC | Stimufend (Biological) | Food and Beverage | In-kind items and services | $224.83 | General |
| Category: Biosimilars | ||||||
| 04/13/2023 | Gilead Sciences, Inc. | Trodelvy (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: ONC | ||||||
| 03/21/2023 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $18.44 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 156 | 194 | $21,689 | $11,712 |
| 2022 | 1 | 16 | 16 | $2,001 | $598.19 |
| 2021 | 2 | 41 | 42 | $8,334 | $2,234 |
| 2020 | 3 | 49 | 51 | $8,308 | $2,046 |
Total Patients
262
Total Services
303
Medicare Billing
$16,590
Procedure Codes
9
All Medicare Procedures & Services
9 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 109 | 137 | $15,428 | $8,213 | 53.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 12 | 21 | $3,849 | $2,024 | 52.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 35 | 36 | $2,412 | $1,475 | 61.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2022 | 16 | 16 | $2,001 | $598.19 | 29.9% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Facility | 2021 | 29 | 29 | $5,626 | $1,473 | 26.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 12 | 13 | $2,708 | $760.64 | 28.1% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Facility | 2020 | 25 | 25 | $4,850 | $1,211 | 25.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 12 | 14 | $1,540 | $454.02 | 29.5% |
| 99202 | New patient office or other outpatient visit, typically 20 minutes | Facility | 2020 | 12 | 12 | $1,918 | $380.10 | 19.8% |
About Kari Zich
Kari Zich is a Nurse Practitioner healthcare provider based in Rochester, Minnesota. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/30/2019. The National Provider Identifier (NPI) number assigned to this provider is 1083255228.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Kari Zich has received a total of $4,070 in payments from pharmaceutical and medical device companies, with $385.70 received in 2024. These payments were reported across 63 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($2,797).
As a Medicare-enrolled provider, Zich has provided services to 262 Medicare beneficiaries, totaling 303 services with total Medicare billing of $16,590. Data is available for 4 years (2020–2023), covering 9 distinct procedure/service records.
Ad
Practice Information
- Specialty Nurse Practitioner
- Other Specialties Family, Nurse Practitioner
- Location Rochester, MN
- Active Since 09/30/2019
- Last Updated 06/26/2025
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1083255228
Products in Payments
- Stimufend (Biological) $899.83
- myRisk (Device) $388.47
- VERZENIO (Drug) $291.18
- MYRISK (Device) $286.49
- KEYTRUDA (Biological) $272.57
- Trodelvy (Drug) $211.42
- LYNPARZA (Drug) $207.81
- Flexitouch Plus (Device) $179.66
- CYRAMZA (Drug) $142.22
- LIBTAYO (Biological) $132.96
- NERLYNX (Drug) $129.00
- Cabometyx (Drug) $125.00
- ZEPZELCA (Drug) $124.71
- INJECTAFER (Drug) $115.79
- TECENTRIQ (Biological) $104.22
- RETEVMO (Drug) $90.01
- Lenvima (Drug) $66.57
- Enhertu (Drug) $29.57
- myChoice CDx (Device) $21.86
- ZEJULA (Drug) $21.72
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Rochester
Dr. Grace Wlasowicz, Rn, Phd, Npp, RN, PHD, NPP
Nurse Practitioner — Payments: $41,479
Nurse Practitioner $41,479
Jamie Carroll, Aprn, APRN
Nurse Practitioner — Payments: $15,059
Nurse Practitioner $15,059
Elizabeth Nafornita, Fnp-C, FNP-C
Nurse Practitioner — Payments: $13,692
Nurse Practitioner $13,692
Brooke Sukalski, Np, NP
Nurse Practitioner — Payments: $12,198
Nurse Practitioner $12,198
Jamie Haraden, Rn, Msn, RN, MSN
Nurse Practitioner — Payments: $12,169
Nurse Practitioner $12,169
Julie Socha, N.p, N.P
Nurse Practitioner — Payments: $10,464
Nurse Practitioner $10,464